With large amounts of data collected and significant room for data submission errors, there is even greater potential to disqualify participating patients or expose subjects to unnecessary risky procedures due to data errors. With more than 30 years of experience as a full-service CRO and core laboratory specializing in cardiology, Cardialysis has an established network of more than 1,200 sites worldwide and works with pharmaceutical, medical device and biotechnology organizations globally.
“We’re responsible for designing, managing, monitoring and reporting on all aspects of clinical-research trials,” said Teun Smits, manager business development at Cardialysis. “As a CRO with core laboratory services working with AG Mednet, we’re experiencing significant efficiencies and convenience for participating clinical sites, and as such we expect even further improvement in the quality of the data collected and transferred compared to past trials. Electronic data submission and collection contributes to our goal of becoming a fully operated eCRO. ”
AG Mednet provides functionality and support to collect clinical trial image data globally, properly de-identify it to ensure regulatory compliance, apply advanced, automated quality-assurance processes to ensure the data is protocol-compliant and readily usable and deliver it reliably and securely to one or more trial repositories.
“With Cardialysis, we’re working on cardiology-related studies with two major medical device companies and more than 1,000 participating patients,” said Abraham Gutman, president and CEO of AG Mednet.